In addition, Cantariño et al. showed that colon cancer patients with high PAD2 expression in the tumor or the adjacent mucosa have the best prognosis and, conversely, the downregulation of PAD2 correlates with poor survival [14]. Here, PADI2 is linked to malignant colon neoplasm.